Summary by Moomoo AI
Eli Lilly and Co officer, Norton Johna, is set to sell 7,056 shares of the company's common stock on 06/03/2024, with an aggregate market value of approximately $5,781,536.93. The shares to be sold were acquired through the vesting of restricted and performance stock unit awards as part of the issuer's equity compensation plan on various dates from 02/01/2021 to 02/10/2023. The total number of shares acquired through these transactions was 7,056, matching the number of shares to be sold. No sales of securities have been reported in the past three months prior to the notice date.